Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ai-xue Liu"'
Autor:
Ai-xue Liu1,2, Jun-chao Wei1,2, Xue-si Chen1,2 xschen@ciac.jl.cn, Xia-bin Jing1,2, Yang Cui3, Yi Liu3
Publikováno v:
Chinese Journal of Polymer Science (World Scientific Publishing Company). May2009, Vol. 27 Issue 3, p415-426. 12p. 1 Black and White Photograph, 3 Diagrams, 7 Graphs.
Publikováno v:
Molecular and Cellular Biology. 21:6906-6912
RhoB is an endosomal small GTPase that is implicated in the response to growth factors, genotoxic stress, and farnesyltransferase inhibitors. To gain insight into its physiological functions we examined the consequences of homozygous gene deletion in
Publikováno v:
Proceedings of the National Academy of Sciences. 98:6192-6197
The effect of neoplastic transformation on the response to genotoxic stress is of significant clinical interest. In this study, we offer genetic evidence that the apoptotic response of neoplastically transformed cells to DNA damage requires RhoB, a m
Autor:
George C. Prendergast, Ai-xue Liu
Publikováno v:
FEBS Letters. 481:205-208
Farnesyltransferase inhibitors (FTIs) induce apoptosis by elevating the levels of geranylgeranylated RhoB (RhoB-GG) in cells. However, the mechanism by which RhoB-GG acts is unclear. Here we report that RhoB-GG is sufficient to mediate the suppressiv
Publikováno v:
Chinese Journal of Cancer Research. 11:164-168
Objective: To study the effect of antisense EGFR RNA on the growth of human glioma cells in vitro and evaluate the feasibility of targeting EGFR gene for gene therapy of gliomas. Methods: Southern and Northern blot analysis, in situ hybridization and
Publikováno v:
Cancer biologytherapy. 2(3)
Knockout mouse studies have established that the transformation-selective death program triggered by farnesyltransferase inhibitor (FTI) requires a gain-of-function in the stress-regulated small GTPase RhoB. To gain insight into this death program, w
Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1
Autor:
George C. Prendergast, Judith F. Baker, Wei Du, James B. DuHadaway, Alexander J. Muller, Diane M Sharp, Scott Donover, Ai–xue Liu
Publikováno v:
Oncogene. 22(23)
Neoplastic transformation sensitizes many cells to apoptosis. This phenomenon may underlie the therapeutic benefit of many anticancer drugs, but its molecular basis is poorly understood. We have used a selective and potent farnesyltransferase inhibit
Publikováno v:
Molecular and cellular biology. 20(16)
Farnesyltransferase inhibitors (FTIs) are in clinical trials, but how they selectively inhibit malignant cell growth remains uncertain. One important player in this process appears to be RhoB, an endosomal Rho protein that regulates receptor traffick
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 05/22/2001, Vol. 98 Issue 11, p6192, 6p, 2 Black and White Photographs, 2 Diagrams, 9 Graphs
Publikováno v:
Chinese Journal of Cancer Research; September 1999, Vol. 11 Issue: 3 p164-168, 5p